Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide. Handa N, Shore ND, Cooperberg MR, Davicioni E, et al. BJU Int 2025;136:920-929.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Handa N, Shore ND, Cooperberg MR, Davicioni E, et al. Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide. BJU Int 2025;136:920-929.
PMID: 40742002